Immune-mediated mechanism in coronavirus fulminant myocarditis.
作者信息
Wei Xin, Fang Yuan, Hu Hongde
机构信息
Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Alley, Chengdu, 610041, PR China.
出版信息
Eur Heart J. 2020 May 14;41(19):1855. doi: 10.1093/eurheartj/ehaa333.
Abstract
摘要
相似文献
1
Immune-mediated mechanism in coronavirus fulminant myocarditis.冠状病毒暴发性心肌炎中的免疫介导机制。
Eur Heart J. 2020 May 14;41(19):1855. doi: 10.1093/eurheartj/ehaa333.
2
Fulminant myocarditis in the time of coronavirus.冠状病毒时期的暴发性心肌炎
Eur Heart J. 2020 Jun 7;41(22):2121. doi: 10.1093/eurheartj/ehaa354.
3
Consideration on pathogen of viral fulminant myocarditis.关于病毒性暴发性心肌炎病原体的思考。
Eur Heart J. 2020 Jun 7;41(22):2120. doi: 10.1093/eurheartj/ehaa356.
4
Is fulminant myocarditis caused by circulating human coronaviruses?暴发性心肌炎是由人冠状病毒感染引起的吗？
Eur Heart J. 2020 May 14;41(19):1854. doi: 10.1093/eurheartj/ehaa330.
5
Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis.糖皮质激素和免疫球蛋白治疗病毒性暴发性心肌炎。
Eur Heart J. 2020 Jun 7;41(22):2122. doi: 10.1093/eurheartj/ehaa357.
6
STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk.病毒性暴发性心肌炎的STAR证据评估：特异性、及时性、可及性、风险。
Eur Heart J. 2020 Sep 7;41(34):3281-3282. doi: 10.1093/eurheartj/ehaa520.
7
Clinically suspected myocarditis in the course of coronavirus infection.冠状病毒感染过程中临床疑似心肌炎。
Eur Heart J. 2020 Jun 7;41(22):2118-2119. doi: 10.1093/eurheartj/ehaa353.
8
The importance of myocardial biopsy in the diagnosis of infectious myocarditis: it still plays a role.心肌活检在感染性心肌炎诊断中的重要性：它仍发挥着作用。
Eur Heart J. 2020 Sep 1;41(34):3280. doi: 10.1093/eurheartj/ehaa425.
9
[Risk factors for acute fulminant myocarditis in children].[儿童急性暴发性心肌炎的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Aug;11(8):627-30.
10
Treatment of Fulminant Giant Cell Myocarditis Associated with Polymyositis Using a Left Ventricular Assist Device and Subsequent Corticosteroid and Immunosuppressive Therapy Leading to Remission.使用左心室辅助装置治疗与多肌炎相关的暴发性巨细胞心肌炎，随后采用皮质类固醇和免疫抑制疗法实现缓解。
Intern Med. 2017 Aug 15;56(16):2155-2158. doi: 10.2169/internalmedicine.8639-16. Epub 2017 Aug 1.
引用本文的文献
1
High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury.新冠病毒肺炎合并心肌损伤患者中白细胞介素6高表达及免疫细胞减少。
Front Immunol. 2023 Jul 26;14:1190644. doi: 10.3389/fimmu.2023.1190644. eCollection 2023.
2
Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes.多系统炎症综合征（MIS-C）：临床特征、治疗和结局的系统评价和荟萃分析。
J Pediatr (Rio J). 2022 Jul-Aug;98(4):338-349. doi: 10.1016/j.jped.2021.08.006. Epub 2021 Dec 3.
3
Focus on Autoimmune Myocarditis in Graves' Disease: A Case-Based Review.聚焦格雷夫斯病中的自身免疫性心肌炎：基于病例的综述
Front Cardiovasc Med. 2021 Jul 7;8:678645. doi: 10.3389/fcvm.2021.678645. eCollection 2021.
4
Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19.直击问题核心：新型冠状病毒肺炎的心肌损伤、凝血功能障碍及其他潜在心血管影响
Int J Vasc Med. 2021 Apr 22;2021:6693895. doi: 10.1155/2021/6693895. eCollection 2021.
5
-From One Tissue to Many Cells: A Review of Single-Cell Transcriptomics in Cardiovascular Biology.从一种组织到多个细胞：单细胞转录组学在心血管生物学中的研究进展。
Int J Mol Sci. 2021 Feb 19;22(4):2071. doi: 10.3390/ijms22042071.
6
Cardiovascular impact of COVID-19 with a focus on children: A systematic review.新冠病毒病对心血管系统的影响（聚焦于儿童）：一项系统综述
World J Clin Cases. 2020 Nov 6;8(21):5250-5283. doi: 10.12998/wjcc.v8.i21.5250.
7
COVID-19: (mis)managing an announced Black Swan.新冠疫情：对已宣布的黑天鹅事件的（不当）应对
Eur Heart J. 2020 May 14;41(19):1779-1782. doi: 10.1093/eurheartj/ehaa435.
8
Pericardial Affections in Patients with COVID-19: A Possible Cause of Hemodynamic Deterioration.新型冠状病毒肺炎患者的心包病变：血流动力学恶化的一个可能原因
Arq Bras Cardiol. 2020 Sep;115(3):569-573. doi: 10.36660/abc.20200474.
9
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.非裔美国人 COVID-19 患者的肺部和心脏病理学：来自新奥尔良的尸检系列。
Lancet Respir Med. 2020 Jul;8(7):681-686. doi: 10.1016/S2213-2600(20)30243-5. Epub 2020 May 27.
本文引用的文献
1
Potential Effects of Coronaviruses on the Cardiovascular System: A Review.冠状病毒对心血管系统的潜在影响：综述。
JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286.
2
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.糖皮质激素联合人免疫球蛋白治疗冠状病毒暴发性心肌炎
Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190.
3
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.致病性人类冠状病毒感染：细胞因子风暴和免疫病理学的成因及后果
Semin Immunopathol. 2017 Jul;39(5):529-539. doi: 10.1007/s00281-017-0629-x. Epub 2017 May 2.
4
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses.冠状病毒的流行病学、基因重组与发病机制
Trends Microbiol. 2016 Jun;24(6):490-502. doi: 10.1016/j.tim.2016.03.003. Epub 2016 Mar 21.
5
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.心内膜心肌活检在心血管疾病管理中的作用：美国心脏协会、美国心脏病学会和欧洲心脏病学会的科学声明。
Circulation. 2007 Nov 6;116(19):2216-33. doi: 10.1161/CIRCULATIONAHA.107.186093. Epub 2007 Oct 24.
Zotero 插件